Abstract
The treatment of acute promyelocytic leukemia (APL) has been based on the administration of all-trans retinoic acid plus anthracycline chemotherapy, which is very effective as first line therapy; however 25 to 30% of patients will relapse with their disease becoming refractory to conventional therapy. Recently, studies have shown arsenic trioxide to be effective in the treatment of acute promyelocytic leukemia. In this study, we used the human leukemia (HL-60) cell line as a model to evaluate the cytoxicity of arsenic trioxide based on the MTT assay. Data obtained from this assay indicated that arsenic trioxide significantly reduced the viability of HL-60 cells, showing LD50 values of 14.26 + 0.5μg/mL, 12.54 + 0.3μg/mL, and 6.4 + 0.6μg/mL upon 6, 12, and 24 hours of exposure, respectively; indicating a dose- and time-dependent response relationship. Findings from the present study indicate that arsenic trioxide is highly cytotoxic to human leukemia (HL-60) cells, supporting its use as an effective therapeutic agent in the management of acute promyelocytic leukemia.
Keywords
Arsenic trioxideAcute promyelocytic leukemiaLeukemiaArsenicAnthracyclineMedicineCytotoxicityCytotoxic T cellChemistryCancer researchPharmacologyRetinoic acidImmunologyInternal medicineBiochemistryIn vitroCancerOrganic chemistry
Affiliated Institutions
Related Publications
Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
Recent data have renewed the interest for arsenic-containing compounds as anticancer agents. In particular, arsenic trioxide (As2O3) has been demonstrated to be an effective dru...
GENOTOXIC MECHANISMS OF ARSENIC TRIOXIDE IN HUMAN JURKAT T-LYMPHOMA CELLS.
Arsenic trioxide (As(2)O(3)) has cytotoxic effects on several cancer cell lines. However, the molecular mechanisms of action remain to be elucidated. Hence, the aim of the prese...
Differential Cytotoxicity and Gene Expression in Human Liver Carcinoma (HepG2) Cells Exposed to Arsenic Trioxide, and Monosodium Acid Methanearsonate (MSMA)
Research in our laboratory has demonstrated that a trivalent form of arsenic such as arsenic trioxide (AT) has the ability to cause significant cytotoxicity, and induction of a ...
Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
Array technologies have made it straightforward to monitor simultaneously the expression pattern of thousands of genes. The challenge now is to interpret such massive data sets....
<i>All-trans</i>-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients
Abstract Abnormal dendritic cell differentiation and accumulation of immature myeloid suppressor cells (ImC) is one of the major mechanisms of tumor escape. We tested the possib...
Publication Info
- Year
- 2006
- Type
- article
- Volume
- 3
- Issue
- 2
- Pages
- 136-140
- Citations
- 58
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
58
OpenAlex
Cite This
Clément G. Yedjou,
Pamela D. Moore,
Paul B. Tchounwou
(2006).
Dose- and Time-Dependent Response of Human Leukemia (HL-60) Cells to Arsenic Trioxide Treatment.
International Journal of Environmental Research and Public Health
, 3
(2)
, 136-140.
https://doi.org/10.3390/ijerph2006030017
Identifiers
- DOI
- 10.3390/ijerph2006030017